News for Omeros Corporation (OMER)

Omeros Corporation's stock surges as narsoplimab data shows 68% lower death risk in HSCT-TMA patients. Click to learn about the potential and risks of OMER stock.

Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings

**media[536557]**

Omeros Corporation (Nasdaq: OMER) today announced statistical sensitivity analysis results related to the primary endpoint analysis for narsoplimab, Omeros' fi

Narsoplimab shows promise in reducing mortality for TA-TMA patients

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.55% to 42,557.62 whil...

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.4% on Thursday. The Dow traded up 0.39% to 42,493.51 while the NASDAQ rose ...

U.S. stocks were higher, with the Dow Jones index gaining over 150 points on Thursday. Shares of Accenture plc ACN rose sharply in today's session after the co...

Omeros stock surges on positive survival data for narsoplimab

Omeros Corporation's (OMER) stock surged 55% after positive trial results for narsoplimab, a potential treatment for stem cell transplant complications. Read more here.

Omeros' stock is volatile, driven by the potential FDA approval of narsoplimab for HSCT-TMA, despite past setbacks including an FDA rejection in 2021. Read more here.

Omeros Corporation (OMER) experienced a significant stock decline of 6.17%, trading at $9.89 per share with a volume of 284,823 shares and a turnover rate of 0.

Omeros Corporation (OMER) experienced a 5.06% stock price increase, reaching $11.62 per share. Trading volume was 294,037 shares with a turnover rate of 0.51% a

MediciNova Inc. (MNOV), a biopharmaceutical company, experienced a notable stock movement with a 5.50% increase, trading at $2.11 per share. The trading volume

U.S. stocks were mixed, with the Dow Jones index gaining more than 150 points on Friday. Shares of Natural Grocers by Vitamin Cottage, Inc. NGVC rose sharply d...

U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday. Shares of Neurogene Inc. NGNE fell sharply in today's ...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%

The allogeneic hematopoietic stem cell transplant market is expected to experience significant growth in the coming years, driven by advances in...